ROYAL BANK OF CANADA - GT BIOPHARMA INC ownership

GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 22 filers reported holding GT BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q3 2023$0
-100.0%
2,436
-36.2%
0.00%
Q2 2023$2,000
+100.0%
3,819
+52.3%
0.00%
Q1 2023$1,000
-99.6%
2,508
-99.1%
0.00%
Q4 2022$250,000
+8233.3%
281,958
+13534.3%
0.00%
Q3 2022$3,000
-50.0%
2,068
+5.6%
0.00%
Q2 2022$6,000
-33.3%
1,958
-35.8%
0.00%
Q1 2022$9,000
-55.0%
3,049
-52.2%
0.00%
Q4 2021$20,000
-28.6%
6,377
+54.3%
0.00%
Q3 2021$28,000
-49.1%
4,134
+15.2%
0.00%
Q2 2021$55,000
-67.1%
3,590
-85.4%
0.00%
Q1 2021$167,00024,5420.00%
Other shareholders
GT BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Baskin Financial Services Inc. 151,354$360.00%
Moss Adams Wealth Advisors LLC 20,000$4,8220.00%
UBS Group AG 8,750$2,1090.00%
Compagnie Lombard Odier SCmA 50,000$12,0550.00%
OSAIC HOLDINGS, INC. 1,270$3050.00%
FMR LLC 150$360.00%
BANK OF AMERICA CORP /DE/ 508$1220.00%
WELLS FARGO & COMPANY/MN 300,697$72,4980.00%
NORTHERN TRUST CORP 32,347$7,7990.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GT BIOPHARMA INC shareholders